UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034728
Receipt number R000039589
Scientific Title Clinical research for assessment of utility and development of outpatient AI interview system
Date of disclosure of the study information 2019/04/01
Last modified on 2022/05/05 22:26:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical research for assessment of utility and development of outpatient AI interview system

Acronym

Clinical research for assessment of utility of outpatient AI interview system

Scientific Title

Clinical research for assessment of utility and development of outpatient AI interview system

Scientific Title:Acronym

Clinical research for assessment of utility of outpatient AI interview system

Region

Japan


Condition

Condition

Outclinic patient

Classification by specialty

Clinical immunology Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to assess the usefulness and problems of the AI interview system in clinical practice and to further reflect these assessment and develop the system.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Satisfaction level for interview among doctors and patients

Key secondary outcomes

Time for patient examination


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Prior interview with conventional paper interview card

Interventions/Control_2

Prior interview with AI interview system

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

In cases where informed consent can be acquired from the principal or substitute of patients, at the visits of outpatient clinic

Key exclusion criteria

Patients who can not obtain informed consent to participate in the study

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Yuko
Middle name
Last name Kaneko

Organization

Department of Internal Medicine, Keio University School of Medicine

Division name

Division of Rheumatology

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-5363-3786

Email

ykaneko.z6@keio.jp


Public contact

Name of contact person

1st name Shuntaro
Middle name
Last name Saito

Organization

Department of Internal Medicine, Keio University School of Medicine

Division name

Division of Rheumatology

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-5363-3786

Homepage URL


Email

shun081359@gmail.com


Sponsor or person

Institute

Division of Rheumatology, Department of Internal Medicine,Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Keio University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Keio University School of Medicine

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

Tel

0333531211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院


Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

439

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 11 Month 02 Day

Date of IRB

2019 Year 02 Month 25 Day

Anticipated trial start date

2019 Year 02 Month 28 Day

Last follow-up date

2022 Year 04 Month 13 Day

Date of closure to data entry

2022 Year 04 Month 13 Day

Date trial data considered complete

2022 Year 04 Month 13 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 31 Day

Last modified on

2022 Year 05 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039589


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name